SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000882104-16-000124
Filing Date
2016-04-21
Accepted
2016-04-20 20:22:49
Documents
7
Period of Report
2016-04-21
Effectiveness Date
2016-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A pdli-041916def14adoc.htm DEF 14A 1207509
2 a2016proxychart.jpg GRAPHIC 33787
3 b2016card1.jpg GRAPHIC 145261
4 b2016card2.jpg GRAPHIC 160233
5 ceosig.jpg GRAPHIC 3893
6 gcsig.gif GRAPHIC 2504
7 pdlilogo2016.jpg GRAPHIC 59351
  Complete submission text file 0000882104-16-000124.txt   1750696
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19756 | Film No.: 161582366
SIC: 2836 Biological Products, (No Diagnostic Substances)